Skip to main content
. 2020 Jul;20(7):816–826. doi: 10.1016/S1473-3099(20)30160-2

Table 1.

Baseline characteristics

Low-dose group (n=6) Intermediate-dose group (n=9) High-dose group (n=9)
Age, years 25·5 (19–37) 29 (23–43) 23 (20–47)
Sex
Male 2 (33%) 2 (22%) 3 (33%)
Female 4 (67%) 7 (78%) 6 (67%)
Ethnicity
White 6 (100%) 9 (100%) 9 (100%)

Data are median (range) or n (%).